265121-04-8,MFCD23102059
Catalog No.:AA00BF0O

265121-04-8 | Fosaprepitant dimeglumine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%(HPLC)
in stock  
$34.00   $24.00
- +
25mg
98%(HPLC)
in stock  
$43.00   $30.00
- +
100mg
98%(HPLC)
in stock  
$107.00   $75.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00BF0O
Chemical Name:
Fosaprepitant dimeglumine
CAS Number:
265121-04-8
Molecular Formula:
C37H56F7N6O16P
Molecular Weight:
1004.8337
MDL Number:
MFCD23102059
SMILES:
Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH]c(=O)n(n1)P(=O)(O)O)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O
Properties
Computed Properties
 
Complexity:
1130  
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
11  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
67  
Hydrogen Bond Acceptor Count:
27  
Hydrogen Bond Donor Count:
15  
Isotope Atom Count:
0  
Rotatable Bond Count:
19  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Downstream Synthesis Route
6284-40-8    265121-01-5   
Fosaprepitantdimeglumine 

[1]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241

[2]Patent:WO2015/83033,2015,A1.Locationinpatent:Page/Pagecolumn11

[3]Patent:WO2010/18595,2010,A2.Locationinpatent:Page/Pagecolumn26

[4]Patent:US2011/130366,2011,A1.Locationinpatent:Page/Pagecolumn9

[5]Patent:WO2012/164576,2012,A2.Locationinpatent:Page/Pagecolumn6-7

[6]Patent:WO2017/93899,2017,A1.Locationinpatent:Page/Pagecolumn17;18

170729-80-3   
Fosaprepitantdimeglumine 

[1]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241

[2]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241

[3]Patent:US2011/130366,2011,A1

[1]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2010/18595,2010,A2Locationinpatent:Page/Pagecolumn28-29

[2]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2011/130366,2011,A1Locationinpatent:Page/Pagecolumn10

[1]Locationinpatent:bodytextSkrdla,PeterJ.;Harrington.,Chandra;Lin.,Zhihao[InternationalJournalofChemicalKinetics,2010,vol.42,#1,p.25-36]

CASUnavailable 
  90191-92-7    265121-04-8 

[1]CurrentPatentAssignee:Sandoz(in:Novartis);NOVARTISAG-WO2011/45817,2011,A2Locationinpatent:Page/Pagecolumn13

Literature

Title: Pranav Prasoon, et al. Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats. Indian J Pharmacol. 2016 Jul-Aug; 48(4): 394-398.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 265121-04-8
Tags:265121-04-8 Molecular Formula|265121-04-8 MDL|265121-04-8 SMILES|265121-04-8 Fosaprepitant dimeglumine
Catalog No.: AA00BF0O
265121-04-8,MFCD23102059
265121-04-8 | Fosaprepitant dimeglumine
Pack Size: 5mg
Purity: 98%(HPLC)
in stock
$34.00 $24.00
Pack Size: 25mg
Purity: 98%(HPLC)
in stock
$43.00 $30.00
Pack Size: 100mg
Purity: 98%(HPLC)
in stock
$107.00 $75.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00BF0O
Chemical Name: Fosaprepitant dimeglumine
CAS Number: 265121-04-8
Molecular Formula: C37H56F7N6O16P
Molecular Weight: 1004.8337
MDL Number: MFCD23102059
SMILES: Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH]c(=O)n(n1)P(=O)(O)O)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O
Properties
Complexity: 1130  
Covalently-Bonded Unit Count: 3  
Defined Atom Stereocenter Count: 11  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 67  
Hydrogen Bond Acceptor Count: 27  
Hydrogen Bond Donor Count: 15  
Isotope Atom Count: 0  
Rotatable Bond Count: 19  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Downstream Synthesis Route
6284-40-8    265121-01-5   
Fosaprepitantdimeglumine 

[1]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241

[2]Patent:WO2015/83033,2015,A1.Locationinpatent:Page/Pagecolumn11

[3]Patent:WO2010/18595,2010,A2.Locationinpatent:Page/Pagecolumn26

[4]Patent:US2011/130366,2011,A1.Locationinpatent:Page/Pagecolumn9

[5]Patent:WO2012/164576,2012,A2.Locationinpatent:Page/Pagecolumn6-7

[6]Patent:WO2017/93899,2017,A1.Locationinpatent:Page/Pagecolumn17;18

170729-80-3   
Fosaprepitantdimeglumine 

[1]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241

[2]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241

[3]Patent:US2011/130366,2011,A1

265121-04-8    172673-20-0 

[1]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2010/18595,2010,A2Locationinpatent:Page/Pagecolumn28-29

[2]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2011/130366,2011,A1Locationinpatent:Page/Pagecolumn10

265121-04-8    170729-80-3 

[1]Locationinpatent:bodytextSkrdla,PeterJ.;Harrington.,Chandra;Lin.,Zhihao[InternationalJournalofChemicalKinetics,2010,vol.42,#1,p.25-36]

CASUnavailable 
  90191-92-7    265121-04-8 

[1]CurrentPatentAssignee:Sandoz(in:Novartis);NOVARTISAG-WO2011/45817,2011,A2Locationinpatent:Page/Pagecolumn13

Building Blocks More >
272437-84-0
272437-84-0
3,4-Dihydro-3-oxo-2h-benzo[b][1,4]thiazine-6-carboxylic acid
AA00BF5N | MFCD00456558
22347-26-8
22347-26-8
1-(2-ETHOXY-PHENYL)-1H-TETRAZOLE-5-THIOL
AA00BFB1 | MFCD03970399
257872-87-0
257872-87-0
4-Chloro-3-(trifluoromethyl)cinnamic acid
AA00BFI1 | MFCD01631407
24287-92-1
24287-92-1
2-Bromo-3-iodothiophene
AA00BG0F | MFCD08234871
280755-12-6
280755-12-6
Tulathromycin B
AA00BGBG | MFCD09839025
214210-17-0
214210-17-0
5-Bromo-2-fluorobenzamide
AA00BGP1 | MFCD03094430
215872-96-1
215872-96-1
2-Chloronicotinaldehyde oxime
AA00BGXQ | MFCD04117788
28599-75-9
28599-75-9
4-(3-chloro-1-adamantyl)-1,3-thiazol-2-amine
AA00BHCB | MFCD01791153
211942-97-1
211942-97-1
4-Cyclopropylthiazole-2-carbaldehyde
AA00BHNV | MFCD07381825
26672-58-2
26672-58-2
4'-(Dimethylamino)propiophenone
AA00BI0W | MFCD01695246
Submit
© 2017 AA BLOCKS, INC. All rights reserved.